Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Subscriptions

Subscriber Registration

Guidelines for Website Users

E-mail Alert Service

Contact Info

Susceptibility for and Clinical Manifestations of Rheumatoid Arthritis Are Associated with Polymorphisms of the TNF-a, IL-1ß, and IL-1Ra Genes

JASMINA TRIFUNOVIC CVETKOVIC, SOLVEIG WÅLLBERG-JONSSON, BIRGITTA STEGMAYR, SOLBRITT RANTAPÄÄ-DAHLQVIST, and ANN KARI LEFVERT

ABSTRACT.

Objective.
To analyze the association of genetic polymorphisms of pro-inflammatory cytokines with rheumatoid arthritis (RA) in comparison with healthy controls from Northern Sweden and the potential contribution of these genetic variants for disease severity and development of cardiovascular complications.

Methods. Polymerase chain reaction amplification was used for analysis of TaqI restriction fragment length polymorphism (RFLP) of interleukin-1 beta (IL-1ß), variable tandem repeat polymorphism of IL-1 receptor antagonist (IL-1Ra) gene and NcoI RFLP at position -308 of tumor necrosis factor-alpha (TNF-a) gene. One hundred and fifty-four patients with RA, 42 men and 112 women, were consecutively recruited into the study through the Department of Rheumatology.

Results. The allele A1 of TNF-a was more common in the patient group (p < 0.01; OR = 1.62). Patients having the genotype A1A2 seemed to develop more severe disease compared with patients with A1A1 genotype: they were younger at disease onset (p < 0.05), had a higher accumulated disease activity (p < 0.05) and worse functional class (p < 0.05). Patients with genotype A2A2 of IL-1ß had higher accumulated disease activity score than patients with A1A1 and A1A2 (p < 0.05). The allelic combination A1 IL-1ß/A2 IL-1Ra was less prevalent in RA patients who developed cardiovascular complications (p < 0.005; OR = 0.20).

Conclusions. The A1 allele of TNF-a associates with RA. Genotypes A1A2 of TNF-a and A2A2 of IL-1ß are associated with more severe disease. The allelic combination A1 IL-1ß/A2 IL-1Ra is less often present in RA patients who developed cardiovascular complications. (J Rheumatol 2002;29:212-9)

Key Indexing Terms:

INTERLEUKIN-1ß
INTERLEUKIN-1 RECEPTOR ANTAGONIST
TUMOR NECROSIS FACTOR ALPHA
POLYMORPHISM
RHEUMATOID ARTHRITIS



Return to February 2002 Table of Contents



© 2002. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.